NucTheraIn private limited is a research-driven healthcare enterprise at the intersection of nuclear medicine, radiochemistry, radiobiology and artificial intelligence. We are committed to developing next-generation solutions that transform diagnostics and therapy through innovation.
By nurturing international collaborations with academic and industrial partners, we drive access to novel isotopes and technologies, positioning the company as a nucleus for scientific innovation.

We are developing AI-driven diagnostic platforms that integrate PET/SPECT-CT/MRI imaging with radiomic and multi-OMIC data. These platforms are designed to support precision oncology and neuro-oncology by enhancing diagnostic accuracy and enabling early disease detection.

We enable the clinical integration by designing and supervising clinical protocols and managing multicentre trials in radiotheranostics. By facilitating large-scale clinical collaborations and data felicitation networks, the company will be building an ecosystem that not only validates new technologies but also creates high-value opportunities for medical, technical, and scientific professionals across the country.